Sep 15, 2008
Phil Riley is Communications Manager for the International Diabetes
Federation (IDF). He is Campaign Director for the World Diabetes
Day campaign, a role he assumed in 2005 for the first year-long
campaign: ‘The IDF Year of the Foot’. Led by Phil, the World
Diabetes Day campaign team were awarded the MIXX Award in 2007 for
Best European New Media Campaign.
Phil was a member of the project management team that drove Phase 1 of the Unite for Diabetes campaign, which resulted in the passage of United Nations Resolution 61/255 in December 2006. He was Deputy Chair of the Promotion and Awareness Working Group that planned and executed the campaign’s media and PR strategy.
Prior to joining the Federation, Phil taught Business Communication at the University of Antwerp, where he pursued an academic career with an interest in how discourse, particularly conversational discourse, is shaped by features of context.
Phil Riley has lived with Type 1 Diabetes for almost 20 years.
Phil was a member of the project management team that drove Phase 1 of the Unite for Diabetes campaign, which resulted in the passage of United Nations Resolution 61/255 in December 2006. He was Deputy Chair of the Promotion and Awareness Working Group that planned and executed the campaign’s media and PR strategy.
Prior to joining the Federation, Phil taught Business Communication at the University of Antwerp, where he pursued an academic career with an interest in how discourse, particularly conversational discourse, is shaped by features of context.
Phil Riley has lived with Type 1 Diabetes for almost 20 years.
Chris asked Phil Riley why diabetes doesn\'t get the funding it deserves. Diabetes is the silent killer. One could look at a patient with a great A1c and no complications as well as patient with an A1c off the chart with complications, and to the untrained the two patients will seem normal. If all the serious implications/complications of this disease presented themselves in the first years of diagnosis, then funding would not be an issue. Very hard to compete with the stark immediacy of cancer, AIDS, etc. Instead these complications build over many years and ultimately crescendo. And even at this point the complications are entirely manageable despite the hardships/pain they inflict on many people. Funding is crucial.